These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 2131947)

  • 1. Eicosanoids and the liver.
    Sinclair S; Levy G
    Ital J Gastroenterol; 1990 Aug; 22(4):205-13. PubMed ID: 2131947
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Hepatic cytoprotection (4). Role of prostaglandins and leukotrienes in experimental hepatotoxicity].
    Ballet F
    Gastroenterol Clin Biol; 1989; 13(8-9):712-9. PubMed ID: 2680728
    [No Abstract]   [Full Text] [Related]  

  • 3. Liver cytoprotection by prostaglandins.
    Quiroga J; Prieto J
    Pharmacol Ther; 1993; 58(1):67-91. PubMed ID: 8415874
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 16, 16 Dimethyl prostaglandin E2 prevents the development of fulminant hepatitis and blocks the induction of monocyte/macrophage procoagulant activity after murine hepatitis virus strain 3 infection.
    Abecassis M; Falk JA; Makowka L; Dindzans VJ; Falk RE; Levy GA
    J Clin Invest; 1987 Sep; 80(3):881-9. PubMed ID: 3624490
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Animal experiment studies on the role of inflammation mediators in corneal neovascularization].
    Rochels R
    Doc Ophthalmol; 1984 May; 57(3):215-62. PubMed ID: 6205837
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Lipid mediators and liver injury].
    Liu Y; Kang GF
    Sheng Li Ke Xue Jin Zhan; 1995 Oct; 26(4):363-6. PubMed ID: 8745570
    [No Abstract]   [Full Text] [Related]  

  • 7. Arachidonic acid derivatives and renal function in liver cirrhosis.
    Laffi G; La Villa G; Pinzani M; Marra F; Gentilini P
    Semin Nephrol; 1997 Nov; 17(6):530-48. PubMed ID: 9353864
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Novel factors playing a role in the pathomechanism of diffuse liver diseases: apoptosis and hepatic stem cells].
    Schaff Z; Nagy P
    Orv Hetil; 2004 Aug; 145(35):1787-93. PubMed ID: 15493221
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Potential role of hepatic macrophages in neutrophil-mediated liver injury in rats with sepsis.
    Doi F; Goya T; Torisu M
    Hepatology; 1993 Jun; 17(6):1086-94. PubMed ID: 8099895
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Roles of lipid mediators in kidney injury.
    Hao CM; Breyer MD
    Semin Nephrol; 2007 May; 27(3):338-51. PubMed ID: 17533010
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Hfgl2/fibroleukin expression in liver and peripheral blood mononuclear cells (PBMC) and its correlation with disease severity].
    Zhu F; Ning Q; Chen Y; Tao XX; Yan WM; Xi D; Yan FM; Hao LJ; Luo XP
    Zhonghua Gan Zang Bing Za Zhi; 2004 Jul; 12(7):385-8. PubMed ID: 15268797
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Proposed role for leukotrienes in the pathophysiology of multiple systems organ failure.
    Sprague RS; Stephenson AH; Dahms TE; Lonigro AJ
    Crit Care Clin; 1989 Apr; 5(2):315-29. PubMed ID: 2650820
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Etoposide prevents apoptosis in mouse liver with D-galactosamine/lipopolysaccharide-induced fulminant hepatic failure resulting in reduction of lethality.
    Nakama T; Hirono S; Moriuchi A; Hasuike S; Nagata K; Hori T; Ido A; Hayashi K; Tsubouchi H
    Hepatology; 2001 Jun; 33(6):1441-50. PubMed ID: 11391533
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Arachidonic acid metabolites in hepatobiliary physiology and disease.
    Kaminski DL
    Gastroenterology; 1989 Sep; 97(3):781-92. PubMed ID: 2666254
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Apoptosis in liver diseases--detection and therapeutic applications.
    Ghavami S; Hashemi M; Kadkhoda K; Alavian SM; Bay GH; Los M
    Med Sci Monit; 2005 Nov; 11(11):RA337-45. PubMed ID: 16258409
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Anti-hepato-cytotoxic serum treatment results in acute liver failure.
    Topuria D; Kakabadze Z; Lobdjanidze N; Chavchanidze N
    Georgian Med News; 2006 Jan; (130):111-5. PubMed ID: 16510928
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Leukotrienes and atherosclerosis: new roles for old mediators.
    Jala VR; Haribabu B
    Trends Immunol; 2004 Jun; 25(6):315-22. PubMed ID: 15145321
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sulindac causes rapid regression of preexisting tumors in Min/+ mice independent of prostaglandin biosynthesis.
    Chiu CH; McEntee MF; Whelan J
    Cancer Res; 1997 Oct; 57(19):4267-73. PubMed ID: 9331087
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Eicosanoid transcellular biosynthesis: from cell-cell interactions to in vivo tissue responses.
    Folco G; Murphy RC
    Pharmacol Rev; 2006 Sep; 58(3):375-88. PubMed ID: 16968946
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prostaglandins, leukotrienes and PAF selectively modulate lymphocyte subset and eosinophil infiltration into the airways in a murine model of asthma.
    Landgraf RG; Nossi DF; Sirois P; Jancar S
    Prostaglandins Leukot Essent Fatty Acids; 2007; 77(3-4):163-72. PubMed ID: 17923399
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.